2021 annual financial data
Redhill Biopharma 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -75.85%.
Operating income was -81,135,000 USD and net income was -97,744,000 USD.
Operating cash flow was -65,047,000 USD.
Get free Redhill Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 85,757,000 USD
- Operating income
- -81,135,000 USD
- Net income
- -97,744,000 USD
- Operating cash flow
- -65,047,000 USD